BioCentury | Nov 17, 2017
Company News

Cue Biopharma in autoimmune deal with Merck

...eligible for $374 million in milestones, plus tiered royalties. The companies will use the biotech's Cue Biologics...
BioCentury | Nov 16, 2017
Company News

Cue Biopharma in autoimmune deal with Merck

...for up to $374 million in milestones, plus tiered royalties. The companies will use Cue's Cue Biologics...
BioCentury | Sep 1, 2017
Company News

Duke spinout Grid gets IP for CFH antibodies

...Duke University (Durham, N.C.) granted Grid Therapeutics LLC (Durham, N.C.), formerly Cue Biologics LLC , exclusive rights to IP...
...26, 2016 ). Duke University , Durham, N.C. Grid Therapeutics LLC , Durham, N.C. Business: Cancer Alicia Parker Duke University Grid Therapeutics LLC Complement...
BioCentury | Aug 22, 2017
Company News

Duke spinout Grid gets IP for CFH antibodies

...Duke University granted Grid Therapeutics LLC (Durham, N.C.), formerly Cue Biologics LLC, exclusive rights to IP covering antibodies that...
...The partners did not respond to inquiries regarding financial details in time for publication. Alicia Parker Duke University Grid Therapeutics LLC Complement...
BioCentury | May 26, 2016
Product R&D

H is for cancer

...suppressed tumors in various cell-based and mouse models of cancer. Now, it is spinning out Cue Biologics...
...Companies and Institutions Mentioned Alexion Pharmaceuticals Inc. (NASDAQ:ALXN), Cheshire, Conn. Atreca Inc., Redwood City, Calif. Cue Biologics...
...inflammation or autoimmunity Development status Preclinical Patents Patent application filed Company; lead investigator Duke University; Cue Biologics...
Items per page:
1 - 5 of 5
BioCentury | Nov 17, 2017
Company News

Cue Biopharma in autoimmune deal with Merck

...eligible for $374 million in milestones, plus tiered royalties. The companies will use the biotech's Cue Biologics...
BioCentury | Nov 16, 2017
Company News

Cue Biopharma in autoimmune deal with Merck

...for up to $374 million in milestones, plus tiered royalties. The companies will use Cue's Cue Biologics...
BioCentury | Sep 1, 2017
Company News

Duke spinout Grid gets IP for CFH antibodies

...Duke University (Durham, N.C.) granted Grid Therapeutics LLC (Durham, N.C.), formerly Cue Biologics LLC , exclusive rights to IP...
...26, 2016 ). Duke University , Durham, N.C. Grid Therapeutics LLC , Durham, N.C. Business: Cancer Alicia Parker Duke University Grid Therapeutics LLC Complement...
BioCentury | Aug 22, 2017
Company News

Duke spinout Grid gets IP for CFH antibodies

...Duke University granted Grid Therapeutics LLC (Durham, N.C.), formerly Cue Biologics LLC, exclusive rights to IP covering antibodies that...
...The partners did not respond to inquiries regarding financial details in time for publication. Alicia Parker Duke University Grid Therapeutics LLC Complement...
BioCentury | May 26, 2016
Product R&D

H is for cancer

...suppressed tumors in various cell-based and mouse models of cancer. Now, it is spinning out Cue Biologics...
...Companies and Institutions Mentioned Alexion Pharmaceuticals Inc. (NASDAQ:ALXN), Cheshire, Conn. Atreca Inc., Redwood City, Calif. Cue Biologics...
...inflammation or autoimmunity Development status Preclinical Patents Patent application filed Company; lead investigator Duke University; Cue Biologics...
Items per page:
1 - 5 of 5